3-oxolup-20(29)-en-28-oyl fluoride | 374902-77-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 3-oxolup-20(29)-en-28-oyl fluoride
• 英文别名: (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysene-3a-carbonyl fluoride
• CAS: 374902-77-9
• 化学式: C₃₀H₄₅FO₂
• 分子量: 456.685
• InChiKey: JOQYIHDAWFQTBF-SVAFSPIFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.3
• 重原子数：
  33
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Triterpenoid derivatives
  申请人：——

  公开号：US20040087560A1

  公开（公告）日：2004-05-06

  The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt, crystal form, complex, hydrate, or hydrolysable ester thereof, in the preparation of a medicament for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use a compound of formula (I) in an assay for detecting the phosphorylation state of cellular substrates. The present invention also relates to novel compounds of formula (I), and the chemical synthesis thereof. 1

  本发明涉及使用式(I)的化合物，或其药用可接受的盐、结晶形式、复合物、水合物或可水解酯，在制备用于治疗患有白血病、癌症或其他增值性疾病的患者的药物中的用途。另一实施例涉及在检测细胞底物的磷酸化状态的测定中使用式(I)的化合物。本发明还涉及式(I)的新化合物及其化学合成。
• TRITERPENOID DERIVATIVES
  申请人：Univerzita palackeho V Olomouci

  公开号：EP1292562A1

  公开（公告）日：2003-03-19
• US7858606B2
  申请人：——

  公开号：US7858606B2

  公开（公告）日：2010-12-28
• [EN] TRITERPENOID DERIVATIVES<br/>[FR] DERIVES TRITERPENOIDES
  申请人：UNIVERZITA PALACKEHO V OLOMOUC

  公开号：WO2001090046A1

  公开（公告）日：2001-11-29

  The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt, crystal form, complex, hydrate, or hydrolysable ester thereof, in the preparation of a medicament for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use a compound of formula (I) in an assay for detecting the phosphorylation state of cellular substrates. The present invention also relates to novel compounds of formula (I), and the chemical synthesis thereof.